Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02365688 · ClinicalTrials.gov registry record · NA
Hemodynamic Response During Goal Directed Fluid Therapy in the OR
A NA study, sponsored by Medtronic - MITG.
- Terminated
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT02365688: Clinical Trial NA study, sponsored by Medtronic - MITG.
NCT02365688 is a NA study that was terminated before completion, run by Medtronic - MITG. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02365688, a NA study, was terminated before completion, sponsored by Medtronic - MITG.
- TERMINATED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to retrospectively evaluate the hemodynamic response to goal directed fluid therapy fluid during open abdominal surgery where goal directed fluid therapy is a standard of care after establishing a pre-incision baseline response to fluids.
Primary Outcome
Physiological parameters compared before and after fluid bolus for fluid resuscitation.
Interventions
- PROCEDURE Initial bolus pre-incision
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-06 |
| Phase | NA |
Why NCT02365688 stopped before completion
NCT02365688 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Initial bolus pre-incision is the first listed.
NCT02365688 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02365688 about?
NCT02365688 is a clinical study titled "Hemodynamic Response During Goal Directed Fluid Therapy in the OR". The purpose of this study is to retrospectively evaluate the hemodynamic response to goal directed fluid therapy fluid during open abdominal surgery where goal directed fluid therapy is a standard of care after establishing a pre-incision baseline response to fluids.
What is the current status of trial NCT02365688?
This trial is currently terminated. It is a NA study. The enrollment target is 18 participants. The study started on 2014-09. Estimated completion is 2015-06.
What interventions are being tested in trial NCT02365688?
The interventions under investigation include: Initial bolus pre-incision (PROCEDURE).
Who is sponsoring clinical trial NCT02365688?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02365688's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia